Literature DB >> 4047353

Surgical decompression of anterior and posterior malignant epidural tumors compressing the spinal cord: a prospective study.

T Siegal, T Siegal.   

Abstract

Of 167 episodes of spinal epidural neoplastic compression, 86 were treated by operation. The surgical approach was prospectively selected according to the location of the tumor in the spinal canal. Decompression was achieved by 61 vertebral body resections (VBRs) and by 25 laminectomies. The indications for operation were: neurological relapse after previous radiotherapy, the need to make a tissue diagnosis, a radioresistant tumor, and neurological deterioration during radiotherapy. Before VBR, 28% (17 of 61) were still able to walk, 51% (31 of 61) were parAparetic, and 21% (13 of 61) were paraplegic. Bowel and bladder dysfunction was present in 49% (30 of 61). After VBR, the outcome of only 57 procedures was available for evaluation because of the postoperative death of 4 patients. Eighty per cent (46 of 57) were able to walk, 18% (10 of 57) were paraparetic, and 2% (1 of 57) were paraplegic. Ninety-three per cent had normal sphincter control. Before laminectomy, 8% (2 of 25) were ambulatory, 84% (21 of 25) were paraparetic, and 8% (2 of 25) were paraplegic. Bowel and bladder dysfunction was present in 76% (19 of 25). After laminectomy, only 23 procedures were evaluated because of the postoperative death of 2 patients. Thirty-nine per cent (9 of 23) were ambulatory, 35% (8 of 23) were paraparetic, and 26% (6 of 23) were paraplegic. Fifty-seven per cent regained normal sphincter control. The operative mortality was 7% (4 of 61) in VBR and 8% (2 of 25) in laminectomy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4047353     DOI: 10.1227/00006123-198509000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  25 in total

1.  Early diagnosis and treatment of spinal epidural metastasis in breast cancer: a prospective study.

Authors:  W Boogerd; J J van der Sande; R Kröger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease.

Authors:  Paul Klimo; Clinton J Thompson; John R W Kestle; Meic H Schmidt
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

Review 3.  Surgical management of spinal mesenchymal tumors.

Authors:  Milan G Mody; Ganesh Rao; Laurence D Rhines
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

4.  Surgical treatment of extradural spinal cord compression due to metastatic tumours.

Authors:  M Coraddu; G C Nurchi; F Floris; V Meleddu
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Multiple spinal epidural metastases; an unexpectedly frequent finding.

Authors:  J J van der Sande; R Kröger; W Boogerd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

6.  Neurosurgical Invasive Techniques for Cancer Pain: A Pain Specialist's View.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

7.  Surgical management of vertebral neoplasia: who, when, how and why?

Authors:  S J Krikler; D S Marks; A G Thompson; W F Merriam; D Spooner
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

8.  Prognostic factors in anterior decompression for metastatic cord compression. An analysis of results.

Authors:  E Sucher; J Y Margulies; Y Floman; G C Robin
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

Review 9.  Solitary plasmacytoma in the thoracic spine. Two case reports.

Authors:  T Takahashi; K Koshu; T Tominaga; A Takahashi; T Yoshimoto
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

10.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.